Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 2,879,742 |
|
|||||
| News | - | ||||||
| Day High | 2.09 | Low High |
|||||
| Day Low | 1.95 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Coherus BioSciences Inc | CHRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.07 | 3.50% | 2.07 | 16:34:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.02 | 1.95 | 2.09 | 2.07 | 2.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,262 | 2,879,742 | $ 2.00 | $ 5,763,657 | - | 1.4301 - 8.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:56:38 | 10 | $ 2.06 | USD |
Coherus BioSciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 228.3M | 111.36M | - | 257.24M | -237.89M | -2.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Coherus BioSciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CHRS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.38 | 2.425 | 1.95 | 2.15 | 1,733,779 | -0.31 | -13.03% |
| 1 Month | 2.48 | 2.61 | 1.95 | 2.33 | 1,994,208 | -0.41 | -16.53% |
| 3 Months | 2.36 | 2.87 | 1.925 | 2.35 | 2,775,966 | -0.29 | -12.29% |
| 6 Months | 3.65 | 3.73 | 1.4301 | 2.51 | 5,049,342 | -1.58 | -43.29% |
| 1 Year | 8.06 | 8.34 | 1.4301 | 3.31 | 4,044,245 | -5.99 | -74.32% |
| 3 Years | 14.42 | 19.32 | 1.4301 | 5.70 | 1,960,644 | -12.35 | -85.64% |
| 5 Years | 14.58 | 23.91 | 1.4301 | 9.17 | 1,628,810 | -12.51 | -85.80% |
Coherus BioSciences Description
| Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. Toripalimab is being evaluated in pivotal clinical trials for the treatment of cancers of the lung, breast, liver, skin, kidney, stomach, esophagus, and bladder. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company is also developing CHS-305, a biosimilar of Avastin. The company generates revenue primarily from the United States. |
